During the past decade, Respiratory Specialists conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Respiratory Specialists" #1 sponsor was "Harmony Biosciences, LLC" with 2 trials, followed by "Actelion" with 1 trials sponsored, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials sponsored, "Suven Life Sciences Limited" with 1 trials sponsored and "Takeda" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Respiratory Specialists" #1 collaborator was "Canadian Heart Research Centre" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Centers for Medicare and Medicaid Services" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Ottawa Hospital Research Institute" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Respiratory Specialists" are "Idiopathic Hypersomnia" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Excessive Daytime Sleepiness" (1 trials), "Narcolepsy" (1 trials) and "Narcolepsy Type 1 (NT1)" (1 trials). Many other conditions were trialed in "Respiratory Specialists" in a lesser frequency.

Most popular intervention types in "Respiratory Specialists" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Pitolisant Oral Tablet" (1 trials), "Placebo oral tablet" (1 trials), "SUVN-G3031" (1 trials) and "Supplemental oxygen therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Respiratory Specialists" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Respiratory Specialists". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Respiratory Specialists, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Respiratory Specialists, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".